arginine vasopressin has been researched along with vasopressin, 1-deamino-4-val-8-arg- in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (59.09) | 18.7374 |
| 1990's | 8 (36.36) | 18.2507 |
| 2000's | 1 (4.55) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Budzikowski, A; Lon, S; Paczwa, P; Szczepanska-Sadowska, E | 1 |
| Federico, P; Pittman, QJ; Veale, WL | 1 |
| Bueno, L; Delrio, C; Gue, M | 1 |
| McGrath, BP; Schwartz, J; Shimizu, K | 1 |
| Adams, EM; Childs, ME; Walker, BR | 1 |
| Hoffman, PL; Szabó, G; Tabakoff, B | 1 |
| Rapp, JP; Snajdar, RM; Thibonnier, M | 1 |
| Kerdelhue, B; Mormede, P; Vincent, JD | 1 |
| Koskimies, O; Pylkkänen, J; Vilska, J | 1 |
| Manning, M; Sawyer, WH | 1 |
| Czakó, L; László, FA | 1 |
| Julesz, J; Laczi, F; Lázló, FA; Mezei, G | 1 |
| Czakó, L; László, F; Manning, M | 1 |
| Chan, WY; Chen, DL; Manning, M | 1 |
| Budzikowski, A; Lon, S; Noszczyk, B; Paczwa, P; Stepniakowski, K; Szczepanska-Sadowska, E | 1 |
| Malendowicz, LK; Markowska, A; Mazzocchi, G; Meneghelli, V; Musajo, F; Nussdorfer, GG | 1 |
| Guibbolini, ME; Lahlou, B; Pierson, PM | 1 |
| Bankowski, K; Haldar, J; Manning, M; Sawyer, WH | 1 |
| Haldar, J; Lowbridge, J; Manning, M; Sawyer, W | 1 |
| Haldar, J; Lowbridge, J; Manning, M; Sawyer, WH; Stier, CT | 1 |
| Balaspiri, L; Haldar, J; Manning, M; Moehring, J; Sawyer, WH | 1 |
| Cheng, LL; Guillon, G; Manning, M; Murat, B; Pena, A; Stoev, S; Szeto, HH; Trueba, M; Ventura, MA; Wo, NC | 1 |
22 other study(ies) available for arginine vasopressin and vasopressin, 1-deamino-4-val-8-arg-
| Article | Year |
|---|---|
Differential effects of V2 vasopressin agonist and antagonists on blood pressure regulation in normotensive (WKY) and spontaneously hypertensive (SHR) rats.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Deamino Arginine Vasopressin; Heart Rate; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Vasopressin; Vasopressins | 1992 |
Vasopressin-induced antipyresis in the medial amygdaloid nucleus of conscious rats.
Topics: Alprostadil; Amygdala; Angiotensin Receptor Antagonists; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arginine Vasopressin; Deamino Arginine Vasopressin; Fever; Injections, Intraventricular; Male; Rats; Receptors, Angiotensin; Receptors, Vasopressin; Vasopressins | 1992 |
CNS vasopressin mediates emotional stress and CRH-induced colonic motor alterations in rats.
Topics: Animals; Arginine Vasopressin; Cerebral Ventricles; Colon; Corticotropin-Releasing Hormone; Deamino Arginine Vasopressin; Electromyography; Electroshock; Gastrointestinal Motility; Injections, Intraperitoneal; Injections, Intraventricular; Male; Muscle, Smooth; Rats; Rats, Inbred Strains; Stress, Psychological | 1992 |
Effects of V2 receptor activity on the pressor response to vasopressin in the rat.
Topics: Animals; Arginine Vasopressin; Autonomic Nerve Block; Blood Pressure; Deamino Arginine Vasopressin; Male; Oxytocin; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Receptors, Vasopressin; Reflex | 1991 |
Direct cardiac effects of vasopressin: role of V1- and V2-vasopressinergic receptors.
Topics: Animals; Arginine Vasopressin; Coronary Vessels; Deamino Arginine Vasopressin; Heart; In Vitro Techniques; Kinetics; Male; Rats; Receptors, Angiotensin; Receptors, Vasopressin; Vasoconstriction; Vasopressins | 1988 |
Receptors with V1 characteristics mediate the maintenance of ethanol tolerance by vasopressin.
Topics: Animals; Arginine Vasopressin; Brain; Deamino Arginine Vasopressin; Drug Tolerance; Ethanol; Male; Mice; Mice, Inbred C57BL; Receptors, Angiotensin; Receptors, Vasopressin | 1988 |
Characterization of vasopressin receptors of rat urinary bladder and spleen.
Topics: Animals; Arginine Vasopressin; Binding, Competitive; Cyclic AMP; Deamino Arginine Vasopressin; Kinetics; Lypressin; Male; Oxytocin; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Receptors, Cell Surface; Receptors, Vasopressin; Sodium Chloride; Spleen; Urinary Bladder | 1986 |
Vasopressin and oxytocin reduce plasma prolactin levels of conscious rats in basal and stress conditions. Study of the characteristics of the receptor involved.
Topics: Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; beta-Endorphin; Deamino Arginine Vasopressin; Dose-Response Relationship, Drug; Endorphins; Male; Oxytocin; Prolactin; Rats; Rats, Inbred Strains; Stress, Physiological; Structure-Activity Relationship | 1986 |
Water intoxication in infants caused by the urine concentration test with vasopressin analogue (DDAVP).
Topics: Administration, Intranasal; Arginine Vasopressin; Deamino Arginine Vasopressin; Female; Humans; Infant; Infant, Newborn; Kidney Concentrating Ability; Male; Water Intoxication | 1984 |
Effective antagonists of the antidiuretic action of vasopressin in rats.
Topics: Adenylyl Cyclase Inhibitors; Animals; Arginine Vasopressin; Chemical Phenomena; Chemistry; Deamino Arginine Vasopressin; Diabetes Insipidus; Diuresis; Dose-Response Relationship, Drug; Oxytocin; Rats; Structure-Activity Relationship; Vasopressins | 1982 |
1-deamino-/4-valine-8-D-arginine/-vasopressin (dVDAVP), a new synthetic vasopressin analog for treating diabetes insipidus.
Topics: Adult; Aged; Arginine Vasopressin; Deamino Arginine Vasopressin; Diabetes Mellitus; Diuresis; Female; Humans; Lypressin; Male; Middle Aged; Valine | 1982 |
Effects of vasopressin analogues (DDAVP, DVDAVP) in the form of sublingual tablets in central diabetes insipidus.
Topics: Adult; Aged; Arginine Vasopressin; Deamino Arginine Vasopressin; Diabetes Insipidus; Humans; Male; Middle Aged; Mouth Floor; Tablets; Valine; Vasopressins | 1981 |
[Treatment of diabetes insipidus with synthetic vasopressin derivatives (effect of 1-deamino-8-D-arginine vasopressin and 1-deamino-valine-8-D-arginine vasopressin)].
Topics: Adult; Aged; Arginine Vasopressin; Deamino Arginine Vasopressin; Diabetes Insipidus; Diuresis; Female; Humans; Male; Middle Aged; Valine | 1980 |
Agonist and antagonist specificities of decidual prostaglandin-releasing oxytocin receptors and myometrial uterotonic oxytocin receptors in pregnant rats.
Topics: Animals; Arginine Vasopressin; Deamino Arginine Vasopressin; Decidua; Dinoprost; Dose-Response Relationship, Drug; Female; Myometrium; Organ Culture Techniques; Oxytocin; Pregnancy; Pregnancy, Animal; Protein Binding; Rats; Rats, Wistar; Receptors, Oxytocin; Stimulation, Chemical | 1994 |
Central AVP and blood pressure regulation: relevance to interspecies differences and hypertension.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Brain; Deamino Arginine Vasopressin; Dogs; Heart; Hypertension; Injections, Intraventricular; Pressoreceptors; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reflex; Species Specificity | 1993 |
Evidence that endogenous arginine-vasopressin (AVP) is involved in the maintenance of the growth and steroidogenic capacity of rat adrenal zona glomerulosa.
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Arginine Vasopressin; Cell Count; Cell Separation; Cell Size; Deamino Arginine Vasopressin; Male; Potassium; Rats; Rats, Wistar; Zona Glomerulosa | 1993 |
A V1-type receptor for mediating the neurohypophysial hormone-induced ACTH release in trout pituitary.
Topics: Adrenocorticotropic Hormone; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Corticotropin-Releasing Hormone; Deamino Arginine Vasopressin; Oncorhynchus mykiss; Oxytocin; Perfusion; Pituitary Gland; Pituitary Hormones, Posterior; Receptors, Vasopressin; Stimulation, Chemical; Vasotocin | 1996 |
Design of potent antagonists of the vasopressor response to arginine-vasopressin.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Diuresis; Female; Methods; Methyltyrosines; Oligopeptides; Penicillamine; Rats; Structure-Activity Relationship; Uterine Contraction | 1978 |
[1-(L-2-hydroxy-3-mercaptopropanoic acid)] analogues of arginine-vasopressin, [8-D-arginine]vasopressin, and [4-valine,8-D-arginine]vasopressin.
Topics: Arginine Vasopressin; Diuresis; Structure-Activity Relationship; Vasopressins | 1977 |
[1-deaminopenicillamine,4-valine]-8-D-arginine-vasopressin, a highly potent inhibitor of the vasopressor response to arginine-vasopressin.
Topics: Animals; Arginine Vasopressin; Deamino Arginine Vasopressin; In Vitro Techniques; Penicillamine; Rats; Vasopressins | 1977 |
Synthesis and some pharmacological properties of deamino(4-threonine,8-D-arginine)vasopressin and deamino(8-D-arginine)vasopressin, highly potent and specific antidiuretic peptides, and (8-D-arginine)vasopressin and deamino-arginine-vasopressin.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Deamino Arginine Vasopressin; Diuresis; Female; In Vitro Techniques; Magnesium; Male; Muscle, Smooth; Rats; Structure-Activity Relationship; Threonine; Uterine Contraction; Vasopressins | 1976 |
Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8.
Topics: Adenylyl Cyclases; Animals; Antidiuretic Agents; Arginine Vasopressin; Cell Line; Cricetinae; Cricetulus; Drug Design; In Vitro Techniques; Inositol Phosphates; Oligopeptides; Oxytocics; Peptides, Cyclic; Protein Isoforms; Radioligand Assay; Rats; Receptors, Oxytocin; Receptors, Vasopressin; Structure-Activity Relationship; Vasoconstrictor Agents | 2007 |